TriSalus Life Sciences, Inc. TLSI Accounts Receivable, Credit Loss Expense (Reversal) Including Writeoffs
Accounts Receivable, Credit Loss Expense (Reversal) Including Writeoffs at other companies
Other financials
Where this comes from
Reported directly by TriSalus Life Sciences, Inc. in its filing.
Tagged under the XBRL concept tlsi:AccountsReceivableCreditLossExpenseReversalIncludingWriteoffs.
The official record: TriSalus Life Sciences, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about TriSalus Life Sciences, Inc.'s accounts receivable, credit loss expense (reversal) including writeoffs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TriSalus Life Sciences, Inc.'s accounts receivable, credit loss expense (reversal) including writeoffs?
- TriSalus Life Sciences, Inc. (TLSI) reported accounts receivable, credit loss expense (reversal) including writeoffs of $52K in Q1 2026.
- How has TriSalus Life Sciences, Inc.'s accounts receivable, credit loss expense (reversal) including writeoffs changed year-over-year?
- TriSalus Life Sciences, Inc.'s accounts receivable, credit loss expense (reversal) including writeoffs increased by 33.3% year-over-year, from $39K to $52K.
- What does accounts receivable, credit loss expense (reversal) including writeoffs mean?
- Measures the expense or reversal associated with estimated uncollectible accounts receivable. It serves as a key indicator of credit risk management and the quality of the company's customer base. High levels of expense suggest potential issues with revenue realization or deteriorating customer financial health.